Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
      Health

      MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF

      July 29, 2026
      Avantor® Reports Second Quarter 2026 Results
      Health

      Avantor® Reports Second Quarter 2026 Results

      July 29, 2026
      Integra LifeSciences Reports Second Quarter 2026 Financial Results
      Health

      Integra LifeSciences Reports Second Quarter 2026 Financial Results

      July 29, 2026
      CENTENE ANNOUNCES BOARD OF DIRECTORS CHANGES
      Health

      CENTENE ANNOUNCES BOARD OF DIRECTORS CHANGES

      July 28, 2026
      Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
      Health

      Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering

      July 27, 2026
      CorVel Corporation to Host Live Earnings Release Webcast
      Health

      CorVel Corporation to Host Live Earnings Release Webcast

      July 27, 2026
      Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
      Health

      Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026

      July 27, 2026
      The Ensign Group Reports Second Quarter 2026 Results
      Health

      The Ensign Group Reports Second Quarter 2026 Results

      July 27, 2026
      RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
      Health

      RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

      July 26, 2026
      Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
      Health

      Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

      July 26, 2026
      « 1 … 4 5 6 7 8 … 262 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026